FDG PET and MRI as biomarkers of Tau pathology in Alzheimer’s disease
Fluorodeoxyglucose Positron Emission Tomography (FDG PET) and Magnetic Resonance Imaging (MRI) are commonly used in a clinical setting as an examination in Alzheimer’s Disease (AD) patients. FDG PET is an imaging tool to evaluate hypometabolism; meanwhile, the MRI observes the brain volume. However,...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | English |
| Published: |
Högskolan i Skövde, Institutionen för biovetenskap
2021
|
| Subjects: | |
| Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-20060 |